Pro-active Monitoring of Vital Signs in Oncology Patients Using a Smartwatch
The Use of Proa-active Monitoring by Measuring Vital Signs Using a Fitbit for a 3-month Period Before, During, and After Chemotherapy in Patients With Cancer
Erasmus Medical Center
175 participants
Jul 1, 2025
OBSERVATIONAL
Conditions
Summary
The goal of this single center prospective observational study is to determine the effect of chemotherapy on (the change in) vital parameters. The main question it aims to answer are: Can changes in vital parameters be measured by using a Fitbit in patients with cancer while undergoing chemotherapy. Participants will be asked to wear a Fitbit for the first two cycles of chemotherapy to evaluate the changes in vital parameters.
Eligibility
Inclusion Criteria5
- Age ≥18 years;
- Diagnosis of stomach or esophageal cancer with an indication of starting chemotherapy
- Knowledge how to handle a Fitbit
- Mastery of Dutch language
- Able and willing to give written informed consent
Exclusion Criteria2
- Cognitive disorders or severe emotional instability
- Already participating in an exercise trial
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Proactive monitoring of vital signs for the duration of the first two cycles of chemotherapy by using a Fitbit
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06680778